
Highly specific and potently activating Vγ9Vδ2-T cell specific nanobodies for diagnostic and therapeutic applications
Keywords: Nanobody; Single-domain antibody fragment; VHH; Gamma delta T cells; Flow cytometry; MACS; Immunocytochemistry; Immunotherapy; Cancer; VHH; variable domain of heavy chain-only Ab; pAg; phosphoantigens; TCR; T cell receptor; PBMC; peripheral blood mononucl